Drug
Pegvaliase
Pegvaliase: highest development phase Post-Market, developed by BioMarin Pharmaceutical. 3 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pegvaliase NCT07477691 | Post-Market | Phenylketonuria |
| Pegvaliase NCT05270837 | Phase 3 | Phenylketonuria (PKU) |
| Pegvaliase NCT03694353 | Phase 3 | Phenylketonuria (PKU) |
Latest
No recent events.
Follow Pegvaliase on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.